Aeterna Zentaris Inc. Made Headway
Mon, Apr 06, 2020 at 05:30 PM
Aeterna Zentaris Inc. (AEZS:NASDAQ) jumped higher at $0.74, representing a gain of 55.7%. On Fri 03 Apr 20, AEZS:NASDAQ hit a New 2-Week Intraday Low of $0.45. The stock got featured on our News Catalysts scanner on Mon 06 Apr 20 at 09:48 AM in the 'MISCELLANEOUS' category. From Fri 20 Mar 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Aeterna Zentaris Inc. (AEZS:NASDAQ)
AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women's health.
Top 10 Gainers:
- Akers Biosciences, Inc. (AKER:NASDAQ), 146.84%
- Immunomedics, Inc. (IMMU:NASDAQ), 99.79%
- Exantas Capital Corp. (XAN:NYSE), 57.55%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 55.72%
- Associated Capital Group, Inc. (AC:NYSE), 48.82%
- Mesoblast Limited (MESO:NASDAQ), 46.67%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 44.23%
- Braemar Hotels & Resorts, Inc. (BHR:NYSE), 43.55%
- Pensare Acquisition Corp. (WRLS:NASDAQ), 43.33%
- Cherry Hill Mortgage Investment Corporation (CHMI:NYSE), 41.52%